2-tert-butyl-1,4-dihydropyridin-4-one, 98%, 250mg

Pentaeritritolo, minimo 98%, per sintesi, 100 g, confezione in plastica.

(2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)-N-(2-(2-(4-formylphenoxy)ethoxy)-4-(4-methylthiazol-5-yl)benzyl)-4-hydroxypyrrolidine-2-carboxamide, 97%, 50mg

(S)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-4-(4-CYANOPHENYL)BUTANOIC ACID, 95%, 100mg

Tetraethylene Glycol Dimethacrylate (stabilized with HQ)>90.0%(GC)100g

7-Chlorothieno[2,3-c]pyridine, 95.0%, 2.5g

t-Butyl dimethylsilane, >95.0%(GC), 10g

4-Chloro-2-nitrobenzaldehyde, 95.0%, 10g

3-(6-Bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 97%, 250mg

2,6-Dichloro-4-fluorobenzoic acid, 95.0%, 1g

(2-methyl-4-oxo-1(4H)-quinolinyl)acetic acid, 95.0%, 1g

1-(2-Amino-5-bromo-4-fluorophenyl)ethanone, 97%, 1g

1-Phenyl-1H-pyrazole-4-carboxylic acid, 95.0%, 25g